Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

41 results about "Mouse Hippocampus" patented technology

Traditional Chinese medicine composition for improving memory and mild cognitive impairment and preparation method thereof

The invention provides a traditional Chinese medicine composition for improving memory and mild cognitive impairment. The traditional Chinese medicine composition comprises 40-80 parts of thinleaf milkwort root-bark, 40-80 parts of grass leaf sweetflag rhizome, 40-80 parts of ginseng, 80-120 parts of tall gastrodia tuber, 80-120 parts of papermulberry fruit, 80-120 parts of ginkgo leaves and 0.01-3 parts of borneol. The traditional Chinese medicine composition can achieve the effects of obviously increasing the number density and surface density of synapse of the molecular layer of mouse hippocampal CA1, obviously enhancing the SOD activities of central cerebral cortex and hippocampus, reducing the content of lipofuscin of the neuron, obviously improving the learning and memory impairment of spontaneous senile dementia model mice, obviously enhancing the activity and fiber density of NOS1 of the central cerebral cortex and hippocampus and obviously up-regulating the contents of SS, AVP and ACTH of the cerebral cortex and hippocampus, especially the content of SS. The traditional Chinese medicine composition can achieve the effect of obviously improving the clinical symptoms of memory and cognitive impairment and has definite curative effects and great application prospects.
Owner:深圳市锦泰医药科技合伙企业有限合伙 +1

Application of ginseng pectin in resisting depressive behavior

InactiveCN105287671AHas antidepressant activityEasy to synthesizeOrganic active ingredientsNervous disorderLocomotor activityBrain-derived neurotrophic factor
The invention relates to application of ginseng pectin in resisting depressive behavior, and belongs to the field of traditional Chinese medicine application. Ginseng pectin is given to a mouse for 12 days in force feeding manner, and the activity of resisting a depressive behavior is evaluated by an open-field locomotor activity test, an elevated plus maze test, a social interference test and a forced swimming test. Results indicate that by using the ginseng pectin, the interference time and frequency in a mouse social interference test can be increased, the invasion time and frequency of the mouse can be reduced, the time rate and frequency rate of an open-arm of the mouse entering an elevated plus maze can be increased, the standing time of the mouse forced swimming test can be reduced, and protein expression of hippocampus beta-catenin and brain-derived neurotrophic factor (BDNF) of the mouse can be increased along with changes of the behaviors, namely the ginseng pectin can be used for enhancing release of transmitters among synapses and connection among synapses by inducing the protein expression of hippocampus beta-catenin and BDNF so as to influence the neuron plasticity and improve neuron development and achieve the activity of resisting the depressive behavior.
Owner:JIANGSU UNIV

Chemical heredity epilepsy persistent state disease animal model and construction method and application thereof

The invention provides a chemical heredity epilepsy persistent state disease animal model and a construction method and application thereof. The epilepsy persistent state disease animal model is a mouse brain kernel group (a hippocampus CA1 region and a thalamus anterior nucleus VA region of a model I); injecting a brain stereotaxic virus (a chemical genetic virus rAAV-CaMKIIa-hM3D (Gq)-mCherry-WPREs-pA) in an apricot kernel BLA region and a thalamus anterior nucleus VA region on the outer side of a substrate of the model II, and embedding an electrode array in a mouse hippocampus CA3 region;after the mouse is recovered for one week, a metabolite CNO of clozapine is injected into the abdominal cavity so that the CNO is combined with a virus expression receptor, neurons are activated to induce epileptic persistent state attack, and the epilepsy persistent state disease animal model is obtained through behavioral observation and in-vivo multichannel local field potential recording judgment. The epilepsy persistent state disease animal model constructed by the method is stable in seizure duration, high in success rate, low in death rate and good in repeatability, and has important significance in researching the origin and formation mechanism of epilepsy persistent state, and screening and mechanism of drug-resistant epilepsy persistent state drugs.
Owner:THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY

New applications of triptorelin

The invention belongs to the field of medicine, and discloses new applications of triptorelin, especially applications of triptorelin in preparation of drugs for inhibiting neuroinflammation. According to the present invention, the experiment results show that triptorelin can inhibit microglia activation, can significantly inhibit LPS-induced inflammatory mediator (TNF-alpha and iNOS) release in mouse hippocampus, and can significantly increase the resolution of new and old things in LPS-induced learning and memory impairment mice, wherein the spontaneous alternation rate in Y maze is increased significantly, such that it is indicated that triptorelin has significant protection effects on LPS-induced learning and memory impairment in mice; and triptorelin has remarkable neuroinflammation inhibition activity, can be used for preparing drugs for preventing and / or treating neuroinflammation, acute and chronic neurodegenerative diseases and other related diseases, and has high clinical application value and development prospect.
Owner:NANHUA UNIV

Medical composition for preventing and treating alzheimer's disease

The invention relates to a medical composition for preventing and treating alzheimer's disease. The medical composition consists of effective components and medically acceptable auxiliary materials. The medical composition is characterized in that the effective components consist of the following components in percentage by weight of 50%-80% of verbascoside and 20%-50% of isoacteoside. The medicalcomposition can obviously improve cognitive disorder of rapid aging(SAMP8) mice, and can reduce accumulation of A beta in hippocampi of SAMP8 mice, inflammatory reaction and oxidative stress, so as to alleviate damage of nerve cells and is notable in effect of preventing and treating alzheimer's disease.
Owner:GUANGZHOU UNIVERSITY OF CHINESE MEDICINE

Construction method and application of AAV vector for specific expression of CRE in mouse hippocampus CA2 region

The invention provides a construction method and application of an AAV virus vector capable of specifically expressing Cre recombinase in a hippocampus CA2 region of a mouse. The construction method comprises following steps: a partial promoter region of a mouse hippocampus CA2 specific expression gene Map3k15 is intercepted to be connected with Cre recombinase and cloned to a pAAV vector withoutan initial promoter. The constructed AAV vector with the Map3k15 promoter connected with Cre recombinase can effectively realize specific overexpression of Cre recombinase in the hippocampus CA2 region of a mouse so as to realize specific regulation and control of neuron activity in the CA2 region; a CA2 neuron tracing and regulating system independent of Cre transgenic mice is established, an effective tool is provided for researching functions of the CA2 region, and a basis is provided for subsequent research on CA2 functional molecular mechanism.
Owner:SOUTHEAST UNIV

Use of protein in preparation of drugs for prevention and treatment of Alzheimer's disease

The invention discloses the use of a protein in preparation of drugs for prevention and treatment of Alzheimer's disease. The amino acid sequence of the protein is shown as SEQ ID NO:2, the protein contains the extracellular fragment 1-171th amino acids of TREM2 receptor protein, and the nucleotide sequence is shown as SEQ ID NO:1. The protein can increase the density of microglial cells, promotethe endocytosis and degradation of microglial cells to Abeta (Amyloid-beta), reduce the intracerebral Abeta level and the deposition of Abeta amyloid plaques, increase the long-term potentiation of CA3-CA1 in the mouse hippocampus region, and strengthen the learning and memory ability of mice.
Owner:XIAMEN UNIV +1

Application of mulberroside A and derivatives thereof in preparation of drug for protecting intestinal barrier

InactiveCN110960539AEasily damagedProtects the gut barrierNervous disorderHydroxy compound active ingredientsInflammatory factorsFructose diet
The invention relates to new application of mulberroside A and its derivative resveratrol in preparation of a drug for protecting the intestinal barrier. In the drug, the mulberroside A or the derivative thereof is an active ingredient. The influence of mulberroside A and its derivative on hippocampus neuroinflammation of high-fructose diet mice, the influence on intestinal barrier damage of high-fructose diet mice and the influence on intestinal flora disorder of high-fructose diet mice are studied through pharmacological experiments. It is found that the mulberroside A and its derivative canobviously inhibit activation of central microglial cells and inflammatory factor level of mice with high fructose diet. It is proved that the mulberroside A and its derivative have the effect of protecting the intestinal barrier, can be used for preparing a drug for preventing and / or treating central nervous inflammation and related neurodegenerative diseases caused by intestinal barrier damage,can remodel intestinal flora disorder caused by high fructose diet and are used for preparing a drug for adjusting intestinal flora disorder.
Owner:NANJING UNIV

Lactobacillus rhamnosus CCFM1228 with functions of relieving depressive emotion and promoting intestinal tract to secrete IgA (Immunoglobulin A) and application of lactobacillus rhamnosus CCFM1228

PendingCN114540245ABoosts serotonin levelsIncreased levels of BDNFMilk preparationNervous disorderPhysiologyHypothalamus
The invention discloses lactobacillus rhamnosus CCFM1228 with functions of relieving depressive mood and promoting intestinal tract to secrete IgA and application of the lactobacillus rhamnosus CCFM1228, and belongs to the technical field of microorganisms. The lactobacillus rhamnosus can relieve depression-like behaviors of depressive mice, increase the content of neurotransmitter 5-hydroxytryptamine in the brain and increase the BDNF level in hippocampus of the depressive mice, and the lactobacillus rhamnosus CCFM1228 has the functions of relieving depressive mood and promoting intestinal tract to secrete IgA. The expression of hypothalamus Crh mRNA is inhibited, the level of corticosterone in serum is reduced, the activity of xanthine oxidase in cerebral cortex is reduced, the activity of adenosine deaminase in liver is improved, and the content of uric acid in serum is reduced; the prefrontal lobe Mbp mRNA level is improved, and the stability of the CNS myelin sheath structure and function is maintained; the mRNA level of the prefrontal lobe Gfap is improved, and the function of astrocytes is enhanced; the mRNA level of hippocampus CD36 is reduced, and immune homeostasis is regulated; the level of IgA in host feces can be improved on the basis of relieving the depression mood, and wide application prospects are achieved.
Owner:JIANGNAN UNIV

Nanocomposite with adenosine wrapped by exosome and application thereof

The invention discloses a nano compound with adenosine wrapped by exosome and application of the nano compound, a nano drug delivery system is developed and designed by wrapping a small molecule drug adenosine by using endogenous carrier mouse hippocampus cell exosome, the particle size of the nano drug delivery system is about 150nm, and the nano drug delivery system is stable in form. The traditional Chinese medicine composition can improve cognitive impairment caused by cerebral ischemia, improve the exploration ability of ischemic mice, improve the learning and memory of the mice, and play a neuroprotective role in behavioral expression; and meanwhile, the reduction of fEPSP slope can be reversed. The compound can be used for preparing ischemic stroke postoperative nerve injury repairing medicines.
Owner:SOUTH CHINA NORMAL UNIVERSITY

Application of inhibitors of miRNA-182, miRNA-188 and miRNA-199a

The invention relates to the technical field of biomedicine technology, and particularly discloses application of inhibitors of miRNA-182, miRNA-188 and miRNA-199a. The therapeutic effect of a miRNA inhibitor AM-182 / 188 / 199a on AD is clarified, specifically, the neuronal function of the hippocampus of AD mice and the plasticity of neuronal neurites are improved, the formation of A[beta] is reduced, the learning and memory ability of the AD mice are improved, new prevention and treatment methods are provided for the clinical treatment of AD, and new ideas are provided for the preparation of drugs for the treatment of AD.
Owner:SHIHEZI UNIVERSITY +1

Application of miR-122 and inhibitor thereof to prevention/treatment of radiation-induced brain injury

ActiveCN111593114AAlleviate neuroinflammatory damageImprove behavioral awarenessNervous disorderMicrobiological testing/measurementInjury brainNasopharyngeal cancer
The invention provides an application of miR-122 and an inhibitor thereof to prevention / treatment of radiation-induced brain injury. Through experimental research, the inventor finds that the expression of miR-122-5p in a radiated mouse hippocampus and a clinical nasopharyngeal cancer radiotherapy patient is significantly raised; but after intervention with the miR-122, neuroinflammation injury can be relieved in a RBI animal model, and behavior recognition can be improved; and in an in vitro cell radiation-induced injury model, restraint of the miR-122 can adjust and control microglia to tendto M2 type polarization.
Owner:AFFILIATED HOSPITAL OF GUANGDONG MEDICAL UNIV

Biomarker for diagnosing Alzheimer's disease and progress of Alzheimer's disease and application of biomarker

The invention belongs to the technical field of biological diagnosis of diseases, and relates to a biomarker for diagnosing Alzheimer's disease and progress of Alzheimer's disease and application of the biomarker. According to the present invention, by detecting the TOM70 mRNA level in the whole blood of the AD patient and the old people with the normal gender and age matching cognitive function, the decrease of the TOM70 mRNA level in the whole blood of the AD patient is found, and the decrease and the AD disease progress are in the negative correlation; mouse hippocampal tissue TOM70 mRNA and protein level detection is carried out, it is found that the APP / PS1 transgenic mouse hippocampal tissue TOM70 level is lowered, and it is proved that the expression level of TOM70 in AD is lowered. The invention provides a novel mRNA biomarker TOM70, and a whole blood TOM70 mRNA and / or TOM70 protein level which can be used for diagnosing the Alzheimer's disease and a marker for the progress of the Alzheimer's disease.
Owner:THE SECOND HOSPITAL OF SHANDONG UNIV

Method to restore or improve cognitive functions

PendingUS20210379146A1Induce autophagyReverse age-related memory declineNervous disorderPeptide/protein ingredientsPharmacometricsMouse Hippocampus
The present invention relates to the field of memory and cognitive functions. Here the inventors show that memory stimulations induce autophagy in the mouse hippocampus, while local pharmacological and genetic modulations of hippocampal autophagy strongly influence memory acquisition. More, the inventors observe that hippocampal autophagy declines during aging and they find that restoring autophagy specifically in the hippocampus of aged mice, following autophagy inducers (such as TAT-Beclin-1), can significantly reverse age-related memory decline. Their results reveal a novel physiological role of autophagy in regulating hippocampal-dependent memory functions, and demonstrate the potential therapeutic benefits of modulating autophagy in order to prevent and / or reverse the deleterious effects of aging on cognitive function. The present invention relates to an activator of the autophagy for use in the restoration and / or improvement of cognitive functions in a subject in need thereof.
Owner:INST NAT DE LA SANTE & DE LA RECHERCHE MEDICALE (INSERM) +2

Application of dioscin to preparation of medicines for treating Alzheimer's diseases

The invention discloses an application of dioscin to preparation of medicines for treating Alzheimer's diseases. The Morris water maze testing result shows that a dioscin administration group can shorten the escaping latency period, prolong original platform quadrant residence time and increase the number of times of passing through a platform, which indicates that the dioscin can significantly improve the spatial learning and memorizing capacity of AD mice; the gait analysis result indicates that the dioscin can significantly increase the gait indexes of the AD mice, and strengthen the physical strength of the AD mice, so that the movement velocity of the AD mice is accelerated, the stride frequency is increased, the stepping length is increased and the duty cycle can be significantly shortened; the dioscin can significantly reduce the MDA level in hippocampal tissue of the AD mice, increase the GSH level and the SOD level, and improve oxidative damage of brain tissue of the AD mice;and the dioscin can restrain AchE activity of the hippocampal tissue, increase ChAT level, influence a cholinergic system, obviously improve the pathology structure of the brain tissue of the AD miceand ultrastructural damage of nerve cells. The dioscin can be used as a single effective component to be prepared into medicines, and can be combined with other medicines for preparing a compound preparation.
Owner:DALIAN MEDICAL UNIVERSITY

New Application of Triptorelin

ActiveCN108904779BInhibit neuroinflammatory activityInhibition of activationNervous disorderPeptide/protein ingredientsDiseaseTriptorelin
The invention belongs to the field of medicine, and discloses new applications of triptorelin, especially applications of triptorelin in preparation of drugs for inhibiting neuroinflammation. According to the present invention, the experiment results show that triptorelin can inhibit microglia activation, can significantly inhibit LPS-induced inflammatory mediator (TNF-alpha and iNOS) release in mouse hippocampus, and can significantly increase the resolution of new and old things in LPS-induced learning and memory impairment mice, wherein the spontaneous alternation rate in Y maze is increased significantly, such that it is indicated that triptorelin has significant protection effects on LPS-induced learning and memory impairment in mice; and triptorelin has remarkable neuroinflammation inhibition activity, can be used for preparing drugs for preventing and / or treating neuroinflammation, acute and chronic neurodegenerative diseases and other related diseases, and has high clinical application value and development prospect.
Owner:NANHUA UNIV

Homologous recombination vector based on HSV-1 as well as target sequence and application of homologous recombination vector

ActiveCN112063658ABuild efficient fast and accurateScreening method is efficient, fast and accurateVirus peptidesStable introduction of DNAMouse HippocampusPromoter
The invention discloses a homologous recombinant vector based on HSV-1 as well as a target sequence and application of the homologous recombinant vector, and provides a set of complete HSV-1 expression vector construction and screening process to optimize an HSV-1 replication-defective central nervous system expression vector, so that efficient insertion and replacement of exogenous genes can be realized. Besides, an optimal latent expression vector construction method is screened out, that is, a complete exogenous gene expression cassette, namely, cBh promoter-repoter Gene-bGH polyA is inserted into a BstEII site in 2.0 Kb Intron at the downstream of an LAP promoter. A recombination virus can realize long-term efficient expression of a reporter gene in a hippocampus of a mouse, and has good safety.
Owner:昆明医科大学第二附属医院

Lactobacillus paracasei CCFM1229 for relieving depressive mood and application thereof

PendingCN114717148AImprove the level ofAlleviate hyperfunctionNervous disorderBacteriaLow serum uric acidHypothalamus
The invention discloses lactobacillus paracasei CCFM1229 for relieving depressive mood and application of the lactobacillus paracasei CCFM1229, and belongs to the technical field of microorganisms. The lactobacillus paracasei can relieve depression-like behaviors of depression mice, increase the content of neurotransmitter 5-hydroxytryptamine in the brain, increase the level of BDNF in hippocampus of the depression mice, inhibit expression of Crh mRNA of hypothalamus and reduce the level of corticosterone in serum; the lactobacillus paracasei can reduce the activity of cerebral cortex xanthine oxidase, improve the activity of liver adenosine deaminase and reduce the content of serum uric acid; the prefrontal lobe Mbp mRNA level is improved, and the stability of the CNS myelin sheath structure and function is maintained; the mRNA levels of prefrontal lobes Grin1, Grin2a and Grin2b can be improved, and the method has very important significance on synaptic plasticity; the lactobacillus paracasei can improve the diversity of intestinal flora and degrade omethoate, and has a wide application prospect.
Owner:JIANGNAN UNIV

Traditional Chinese medicine composition for treating Alzheimer disease and preparation method of composition

The invention relates to a traditional Chinese medicine composition for treating Alzheimer disease and a preparation method of the composition. The composition is prepared from the following traditional Chinese medicine raw materials in parts by weight: 120-200 parts of fructus alpiniae oxyphyllae and 30-80 parts of fructus schisandrae chinensis. The composition has the following advantages: (1) the composition can reverse brain damage of Alzheimer disease model mice induced by unilateral intraventricular injection of Abeta1-42 in a dose-dependent manner, and significantly improve learning andmemory disorders by improving the oxidative stress response and neurons induced by the Abeta1-42; and (2) the composition can significantly reduce the levels of IL-1beta and IL-6 in the hippocampus of Alzheimer disease model mice induced by unilateral intraventricular injection of lipopolysaccharide, and the level of IL-1beta in the cortex, and significantly improve the learning and memory disorders.
Owner:SHENYANG PHARMA UNIVERSITY

TARGETING P18 FOR mTOR-RELATED DISORDERS

Accumulating evidence indicates that the lysosomal Ragulator complex is essential for full activation of the mechanistic target of rapamycin complex 1 (mTORC1). Abnormal mTORC1 activation has been implicated in several developmental neurological disorders, including Angelman syndrome (AS), which is caused by maternal deficiency of the ubiquitin E3 ligase UBE3A. Here, it is reported that Ube3a regulates mTORC1 signaling by targeting p18, a subunit of the Ragulator. Ube3a ubiquinates p18, resulting in its proteasomal degradation, and Ube3a deficiency in the hippocampus of AS mice induces increased lysosomal localization of p18 and other members of the Ragulator-Rag complex, and increased mTORC1 activity. p18 knockdown in hippocampal CA1 neurons of AS mice reduces elevated mTORC1 activity and improves dendritic spine maturation, long-term potentiation (LTP), as well as learning performance. The results described herein indicate that Ube3a-mediated regulation of p18 and subsequent mTORC1 signaling is critical for typical synaptic plasticity, dendritic spine development, and learning and memory.
Owner:WESTERN UNIV OF HEALTH SCI

Application of Cistanche deserticola polysaccharide in medicine preparation used for improving learning memory function

InactiveCN102743408ANootropicReduce AChE activity contentOrganic active ingredientsNervous disorderMechanism of actionMouse Hippocampus
The invention discloses an application of Cistanche deserticola polysaccharide in medicine preparation used for improving learning memory function, and is characterized in that a channel water labyrinth and a Morris labyrinth are used for respectively discussing the influences of the mouse learning memory acquired obstacle caused by Cistanche deserticola polysaccharide on the scopolamine hydrobromide, the mouse learning memory reproducibility obstacle caused by ethanol and the mouse learning memory consolidation obstacle, which show that the Cistanche deserticola polysaccharide has intelligence promotion effect, and the application provided by the invention makes a research for a effect mechanism that the Cistanche deserticola polysaccharide improves the learning memory function to reduce the mouse hippocampus and cerebral cortex AChE active content and increase the content of Ach in brain.
Owner:INNER MONGOLIA MEDICAL COLLEGE

Application of chitosan nanogel loaded with oxytocin in preparation of medicine for early intervention of Alzheimer's disease

The invention relates to an application of chitosan nanogel loaded with oxytocin in preparation of a medicine for early intervention of Alzheimer's disease. The research finds that the chitosan nanogel loaded with oxytocin has a remarkable effect in the aspect of early treatment of the Alzheimer's disease. Cellular level experiment results show that the chitosan nanogel loaded with the oxytocin can inhibit microglial cell activation caused by lipopolysaccharide and reduce expression of inflammatory factors in microglial cells. Animal level experiment results show that the chitosan nanogel loaded with the oxytocin can significantly reduce the expression level of inflammatory factors of hippocampus of an early model mouse with the Alzheimer's disease, significantly reduce beta-amyloid protein deposition and neuron damage, and significantly improve the learning and memory ability of the early model mouse with the Alzheimer's disease. The chitosan nanogel loaded with the oxytocin is simple in preparation process, mild in reaction condition and easy in surface modification.
Owner:TIANJIN MEDICAL UNIV

A traditional Chinese medicine composition for improving memory and mild cognitive impairment and preparation method thereof

The invention provides a traditional Chinese medicine composition for improving memory and mild cognitive impairment. The traditional Chinese medicine composition comprises 40-80 parts of thinleaf milkwort root-bark, 40-80 parts of grass leaf sweetflag rhizome, 40-80 parts of ginseng, 80-120 parts of tall gastrodia tuber, 80-120 parts of papermulberry fruit, 80-120 parts of ginkgo leaves and 0.01-3 parts of borneol. The traditional Chinese medicine composition can achieve the effects of obviously increasing the number density and surface density of synapse of the molecular layer of mouse hippocampal CA1, obviously enhancing the SOD activities of central cerebral cortex and hippocampus, reducing the content of lipofuscin of the neuron, obviously improving the learning and memory impairment of spontaneous senile dementia model mice, obviously enhancing the activity and fiber density of NOS1 of the central cerebral cortex and hippocampus and obviously up-regulating the contents of SS, AVP and ACTH of the cerebral cortex and hippocampus, especially the content of SS. The traditional Chinese medicine composition can achieve the effect of obviously improving the clinical symptoms of memory and cognitive impairment and has definite curative effects and great application prospects.
Owner:深圳市锦泰医药科技合伙企业有限合伙 +1

Application of triptorelin

The application belongs to the field of medicine, and discloses the application of triptorelin, especially the application of triptorelin in the preparation of medicaments for treating depression. Experiments have shown that in the forced swimming test, triptorelin can significantly reduce the immobility time of depression model mice induced by chronic restrictive stress, lipopolysaccharide, plantar injection of CFA and early social isolation, indicating that it has a positive effect on depression model mice. Obvious improvement. At the same time, triptorelin can significantly increase the expression of chronic restrictive stress-induced mouse hippocampal BDNF and neuronal synaptic plasticity-related genes c-fos, egr1, arc, npas4. Therefore, triptorelin has significant antidepressant activity, can be used to prepare medicines for treating depression, and has high clinical application value and development prospect.
Owner:NANHUA UNIV

Traditional Chinese medicine composition for treating sepsis cognitive disorder and preparation method of composition

The invention discloses a traditional Chinese medicine composition for treating sepsis cognitive disorder and a preparation method of the composition. The traditional Chinese medicine composition comprises the following components in parts by weight: 30-60 parts of ginseng, 60-120 parts of radix aconiti lateralis preparata, 30-60 parts of raw rhubarb, 20-40 parts of rhizoma gastrodiae, 10-30 partsof folium ginkgo, 10-30 parts of cassia twig and 5-20 parts of radix scutellariae. The fEPSP (Field Post-Synaptic Potential) of the hippocampus CA1 region of a sepsis mouse is recorded with a nerve electrophysiology technology, and the slope, namely, the LTP (Long-Term-Depression) amplitude is analyzed. Experiments find that the LTP of the hippocampus CA1 region of the sepsis mouse is remarkablyreduced, and the traditional Chinese medicine composition can remarkably improve the LTP of the hippocampus region and has a certain effect on improvement of sepsis cognitive disorder when applied totreatment.
Owner:BEIJING CHINESE MEDICINE HOSPITAL AFFILIATED CAPITAL MEDICAL UNIV

An auxiliary positioning device for mouse brain injection

ActiveCN110478079BHigh precisionSolve problems that are too small to pinpointIntravenous devicesAnimal fetteringMedicineEngineering
The invention discloses an auxiliary positioning device for mouse brain injection, which comprises a constant temperature base plate, a vertical axis moving scale and a clamping assembly. The four corners of the lower surface of the constant temperature base plate are threaded with non-slip feet, and the inside of the constant temperature base plate is installed with A constant temperature heating assembly, a fixed component is fixed on the rear side of the upper surface of the constant temperature bottom plate, the vertical axis moving scale is installed on the left surface of the constant temperature bottom plate, and the upper end of the vertical axis moving scale is fixed with a vertical plate, the inside of the vertical axis A screw is installed in the middle position, and the top of the screw is welded with an adjustment handle. The outer wall of the screw is threaded with a ball slide, and the right side of the ball slide is equipped with a horizontal axis moving scale, and the clamping assembly is installed on the horizontal axis. Move the ruler below. The present invention greatly improves the accuracy of the entire positioning device by adopting a moving scale with a positioning accuracy of 0.01mm, thus solving the problem in the prior art that precise positioning cannot be performed due to the small hippocampus of mice.
Owner:NANTONG UNIVERSITY

Application of hydrogen and hydrogenated coral calcium in preparation of medicines for treating hyperpyrexia and mental disorder caused by methylamphetamine

The invention relates to the technical field of anti-mental disorder medicines, in particular to application of hydrogen and hydrogenated coral calcium in preparation of medicines for treating hyperpyrexia and mental disorder caused by METHs (Methamphetamine). Experimental research shows that hydrogen can relieve hyperpyrexia and depression-like behaviors caused by METH and effectively relieve the depression state in the METH withdrawal process, so that METH withdrawal can be facilitated. Hydrogenated coral calcium can continuously generate hydrogen in a body, after administration, the hydrogen concentration in the body can reach a high level, the hydrogen can be continuously released in the body, serious hyperpyrexia caused by exposure of METH can be remarkably reduced, depression-like behaviors can be inhibited, and damage of METH to mouse hippocampus synaptic plasticity is remarkably improved.
Owner:HEBEI MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products